AH Capital Management L L C's Q3 2024 13F: 1 new position, 1 exit
Form 13F-HR for the quarter ended Sep 30, 2024 · filed Nov 13, 2024 · 13 reported positions · accession 0001104659-24-117708
What changed this quarter
| Activity | Security | Weight before | Weight now | Change | Shares | Shares % |
|---|---|---|---|---|---|---|
| Reduced | MAPLEBEAR INC (CART) | 15.4% | 10.0% | −5.3 pts | −2.8M sh | −50% |
| New | BIOAGE LABS INC (BIOA) | — | 5.5% | +5.5 pts | +3.01M sh | new |
| Exited | SHAPEWAYS HOLDINGS INC (SHPWQ) | 0.0% | — | 0.0 pts | −598K sh | −100% |
Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled
† Security identifier (CUSIP) changed — read as one continuing position, not an exit and a new position:
- CYNGN INC (CYN): 23257B107 → 23257B206, 5.76M → 57,584 shares (share count changed with the identifier; not shown as a trade)
- GINKGO BIOWORKS HOLDINGS INC (DNA): 37611X100 → 37611X209, 4.34M → 109K shares (share count change consistent with a stock split)
Top 10 positions — 99.2% of the equity book
Changes in the top 10 this quarter: BIOA entered · ERAS left
| # | Security | Weight before | Weight now | |
|---|---|---|---|---|
| 1 | ROBINHOOD MKTS INC (HOOD) | 36.7% | 39.0% | |
| 2 | SAMSARA INC (IOT) | 11.5% | 16.9% | |
| 3 | REVOLUTION MEDICINES INC (RVMD) | 9.1% | 11.0% | |
| 4 | MAPLEBEAR INC (CART) | 15.4% | 10.0% | |
| 5 | BLOCK INC (XYZ) | 5.6% | 6.0% | |
| 6 | BIOAGE LABS INC (BIOA) | 0.0% | 5.5% | Entered the top 10 |
| 7 | NAUTILUS BIOTECHNOLOGY INC (NAUT) | 3.5% | 4.4% | |
| 8 | DOORDASH INC (DASH) | 14.8% | 3.5% | |
| 9 | ACCOLADE INC (ACCD) | 1.6% | 1.8% | |
| 10 | OPENDOOR TECHNOLOGIES INC (OPEN) | 1.0% | 1.1% | |
| — | ERASCA INC (ERAS) | 0.6% | 0.7% | Left the top 10 |
Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).